Brief: Sun Pharma Says U.S. Court Affirms Summary Judgment In Favor Of Sun Pharmaceutical In Lipitor Antitrust Litigation
BRIEF-Sun Pharma Says U.S. Court Affirms Summary Judgment In Favor Of Sun Pharmaceutical In Lipitor Antitrust Litigation Aug 17 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:
SUN PHARMA - U.S. COURT AFFIRMS SUMMARY JUDGMENT IN FAVOR OF SUN PHARMACEUTICAL IN LIPITOR ANTITRUST LITIGATION
SUN PHARMA - APPELLATE COURT AFFIRMS DENIAL OF CLASS CERTIFICATION FOR PLAINTIFFS IN LIPITOR CASE
Source text: ID:nBSE14f8sD
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses